Systemic Lupus Erythematosus: A Review. (PubMed, JAMA) - Apr 9, 2024 - "Hydroxychloroquine is first-line therapy and reduces disease activity, morbidity, and mortality. When needed, additional immunosuppressive and biologic therapies include azathioprine, mycophenolate mofetil, cyclophosphamide, belimumab, voclosporin, and anifrolumab."
Journal • Review • Chronic Kidney Disease • Glomerulonephritis • Hematological Disorders • Immunology • Inflammation • Inflammatory Arthritis • Lupus • Lupus Nephritis • Musculoskeletal Diseases • Nephrology • Renal Disease • Rheumatology • Systemic Lupus Erythematosus
|
|
Caroline H Siegel; Lisa R Sammaritano
|